Heart failure & cardiomyopathies

Functional and Prognostic Implications of Different Iron Deficiency Definitions in Heart Failure: Insights From HEART-FID

JACC Heart FailPublished Secondary analysis of the HEART-FID randomised trial

Authors' conclusion

Despite ferritin <100 ng/mL being the most common ID criteria met in HEART-FID, Tsat and iron and their changes over time, more than ferritin, were related to functional capacity, hemoglobin levels, and prognosis.

Study context

Population
Patients with heart failure (HF), LVEF ≤40% and iron deficiency (ID) (ferritin <100 ng/mL or <300 ng/mL with transferrin saturation (Tsat) <20%) in the HEART-FID trial of ferric carboxymaltose vs placebocomplete baseline iron studies
Participants
2,951 patients
Comparison
Different ID definitions and iron indices (ferritin, Tsat, serum iron) in relation to functional capacity, hemoglobin and outcomes
Methodological detailsplacebo-controlled
  • Placebo-controlled

Primary result

As reported in the abstract

Fulfilment of ID criteria and association with hemoglobin, functional capacity and outcomes · baseline

Ferritin <100 ng/mL

89.8%

Iron <13 μM

59.8%

Tsat <20%

40.5%

Ferritin <30 ng/mL

31.1%

Further findings

Tsat and iron remained associated with hemoglobin and 6MWD after multivariable adjustment; changes in Tsat and iron over 6 months related to changes in hemoglobin and 6MWD

Original publication

Functional and Prognostic Implications of Different Iron Deficiency Definitions in Heart Failure: Insights From HEART-FID. JACC Heart Fail. Published 25 October 2025. doi:10.1016/j.jchf.2025.102661

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.